| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Debt-to-equity | 22.4 | % | +651% |
| Return On Equity | -341 | % | -263% |
| Return On Assets | -279 | % | -206% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 13.3M | shares | +3.07% |
| Common Stock, Shares, Outstanding | 13.2M | shares | +2.37% |
| Entity Public Float | 101M | USD | +78.5% |
| Common Stock, Value, Issued | 13.2K | USD | +2.37% |
| Weighted Average Number of Shares Outstanding, Basic | 13M | shares | +1.3% |
| Weighted Average Number of Shares Outstanding, Diluted | 13M | shares | +1.3% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 13M | USD | +68.2% |
| General and Administrative Expense | 3.06M | USD | +87.8% |
| Operating Income (Loss) | -16M | USD | -71.7% |
| Net Income (Loss) Attributable to Parent | -15.8M | USD | -77.6% |
| Earnings Per Share, Basic | -1.21 | USD/shares | -75.4% |
| Earnings Per Share, Diluted | -1.21 | USD/shares | -75.4% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 4.09M | USD | -41.5% |
| Assets | 4.09M | USD | -41.5% |
| Accounts Payable, Current | 554K | USD | |
| Employee-related Liabilities, Current | 75.9K | USD | +99.3% |
| Liabilities, Current | 1.56M | USD | +430% |
| Liabilities | 1.56M | USD | +430% |
| Retained Earnings (Accumulated Deficit) | -66.2M | USD | -31.3% |
| Stockholders' Equity Attributable to Parent | 2.53M | USD | -62.2% |
| Liabilities and Equity | 4.09M | USD | -41.5% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -1.78M | USD | -14.5% |
| Net Cash Provided by (Used in) Financing Activities | 299K | USD | |
| Common Stock, Shares Authorized | 100M | shares | 0% |
| Common Stock, Shares, Issued | 13.2M | shares | +2.37% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.48M | USD | +4.71% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 4.09M | USD | -41.5% |
| Deferred Tax Assets, Valuation Allowance | 6.3M | USD | +39.8% |
| Deferred Tax Assets, Operating Loss Carryforwards | 6.3M | USD | +39.8% |
| Share-based Payment Arrangement, Expense | 4.22M | USD | +129% |